Early Warning Beta-lactamases Detection
Detection of antibiotic-resistance enzymes (e.g., staphylococcal penicillinase, ESBLs in Enterobacteriaceae, E. coli)
CommercialActive
Key Facts
Indication
Detection of antibiotic-resistance enzymes (e.g., staphylococcal penicillinase, ESBLs in Enterobacteriaceae, E. coli)
Phase
Commercial
Status
Active
Company
About Molsid
Molsid is a private, innovative biotech/medtech company addressing the critical global challenge of antimicrobial resistance (AMR) through rapid diagnostics. Its core technology is the SmartID® platform of fluorogenic biotracers, which enable the detection of specific bacterial enzyme activity, such as beta-lactamases, directly from primary clinical samples in as little as two hours. The company has two main product lines: 'Early Warning Beta-lactamases Detection' tests and 'Rapid Antimicrobial Susceptibility Testing' (AST) kits, positioning it in the growing market for rapid, actionable infectious disease diagnostics.
View full company profile